736 A clinical stage engineered toxin body (ETB) targeting PD-L1 (MT-6402) induces peripheral pharmacodynamic responses unique from PD-L1 monoclonal antibodies
Autor: | Swati Khanna, Rachael Orlandella, Elizabeth Saputra, Sydney Matthews, Lydia Navarrete-Galvan, Sara LeMar, Joseph Dekker, Eric Poma, Chris Moore |
---|---|
Rok vydání: | 2022 |
Zdroj: | Regular and Young Investigator Award Abstracts. |
DOI: | 10.1136/jitc-2022-sitc2022.0736 |
Databáze: | OpenAIRE |
Externí odkaz: |